Canopy Growth stock drops 3.13% as early selling pushes price below session highs

Traders Union
All News
Financial News
Canopy Growth slides 3.13% to $1.09

Highlights

Canopy Growth relaunched its Tweed brand in Germany, introducing new strains via its MTL Cannabis subsidiary to expand global medical cannabis access.
The German market entry is Tweed’s first international expansion since acquiring MTL Cannabis, supporting long-term growth despite prevailing sector-wide selling pressure.
Technicals signal short-term buyer momentum above support, but persistent resistance and weak weekly trends point to a likely sideways-to-lower price range of $0.87–$1.15 near term.

Global expansion as Tweed launches in Germany, sentiment subdued by selling

Canopy Growth Corporation completed the relaunch of its Tweed brand in the German medical cannabis market, introducing three new cannabis strains developed by its subsidiary, MTL Cannabis Corp. This marks the initial international rollout of Tweed products following the company's acquisition of MTL Cannabis, representing an expansion of Canopy Growth's global product footprint. The introduction of new strains into the German market brings added regulatory access and could support long-term growth objectives, though price action has remained under broader selling pressure.

Momentum divergence as mid-term support holds amid mixed signals

On the technical side, the CGC price sits above the MA-20 at $1.08 and the MA-50 at $1.07, with the MA-200 overhead at $1.22. The Ichimoku Kijun level at $1.23 serves as nearby resistance. MACD on the daily chart signals strong selling pressure, while the ADX is neutral, indicating uncertain trend strength. The RSI stands at 54.61 (Buy), reflecting a lack of clear overbought or oversold conditions, but the Stoch RSI is deeply overbought and the CCI remains neutral. BBP points to intraday buyer dominance, while the Awesome Oscillator is neutral, and overall, momentum and oscillators are divergent. The session opened flat and slipped to the lower end of the $1.09–$1.12 range with low intraday volatility, revealing visible weakness after the open.

Downside risk rises as technical signals favor bearish outlook

For the coming week, Canopy Growth is expected to trade within a $0.87–$1.15 volatility band relative to current levels. There is a low probability (less than 20%) of a sustained price increase, with a decline the more likely path under the prevailing setup, as weekly moving averages and key oscillators continue to signal downside risk. The base case calls for continued sideways price movement as short-term buyers confront strong resistance. A bullish break above $1.23 could open the way for further gains, while a sustained move below $0.87 would bring new lows into focus.

Viktoras Karapetjanc, expert at Traders Union, sees Canopy Growth's relaunch of Tweed in Germany as a strong step in expanding its global footprint. He believes the international introduction of new strains supports the company's long-term fundamentals but notes the stock remains under selling pressure. Technicals suggest sideways action with prevailing downside risk. Still, macro and regulatory drivers favor patient optimism if broader sentiment improves. "If Canopy Growth holds above the $1.07–$1.08 region and delivers on its global strategy, I see scope for renewed upside in the coming months."

Earlier, analysts noted that Canopy Growth was experiencing short-term technical resilience but faced ongoing longer-term uncertainty and cautious sentiment. The latest developments reinforce this outlook, with traders advised to monitor for a decisive move above resistance at $1.23 or a breakdown below $0.87, either of which could set the tone for the next major trend.

Source of Data: CGC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.